secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001628280-25-006036
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q4 revenue down 38% to $119M; EPS $0.07; guides Q1 loss
----------------------------------------------------------------

- Q4 revenue $119M (-37.7% YoY); active earning coaches 27,100 (-34.1% YoY).
- Net income $0.8M ($0.07 diluted EPS); non-GAAP adjusted EPS $0.10.
- Full year 2024 revenue $602.5M (-43.8%); net income $2.1M ($0.19 EPS).
- Q1 2025 guidance: revenue $100-$120M, EPS loss $0.50 to $0.00 per share.
- Cash & investments $162.3M, no debt; cites GLP-1 market headwinds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828025006036/0001628280-25-006036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828025006036/med-20250218.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-006036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer